MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3

Li,Yuan; Luo,Tianyou; Wang,Liang; Wu,Jing; Guo,Shixin

doi:10.3892/ijmm.2016.2748

MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3

Authors:
- Yuan Li
- Tianyou Luo
- Liang Wang
- Jing Wu
- Shixin Guo
View Affiliations

Affiliations: Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 410000, P.R. China
Published online on: September 23, 2016 https://doi.org/10.3892/ijmm.2016.2748
Pages: 1515-1524

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs or miRs), a group of small non-coding RNAs, have been demonstrated to play key roles in various physicological processes and diseases, including diabetes, the most common metabolic disorder. However, the underlying mechanisms remains largely unknown. In this study, we aimed to investigate the role of miR‑19a‑3p in diabetes. The results of RT-qPCR demonstrated that the level of miR‑19a‑3p was significantly decreased in the diabetic patients, and that the decreased miR‑50a-5p level was significantly associated with a high concentration of blood glucose. miR‑19a‑3p mimic was further used to transfect pancreatic β cells, and we found that the overexpression of miR-19a-3p promoted cell proliferation and insulin secretion, while it suppressed the apoptosis of pancreatic β cells. Suppressor of cytokine signaling 3 (SOCS3) was further identified as a direct target gene of miR‑19a‑3p, and its protein level was significantly decreased following the overexpression of miR‑19a‑3p. Moreover, the siRNA-induced downregulation of SOCS3 also enhanced cell proliferation and insulin secretion, while it inhibited the apoptosis of pancreatic β cells. In addition, the overexpression of SOCS3 reversed the effects of miR‑19a‑3p overexpression on cell proliferation, insulin secretion and on the apoptosis of pancreatic β cells, which further indicates that SOCS3 acts as a downstream effector in the miR-19a-3p-mediated function of pancreatic β cells. Finally, the level of SOCS3 was increased in diabetic patients, and inversely correlated with the miR‑19a‑3p level, suggesting that the downregulation of miR-19a-3p leads to the upregulation of SOCS3, which contributes to the dysfunction of pancreatic β cells. On the whole, the findings of this study suggest that miR‑19a‑3p plays an important role in β cell function, and that the miR-19a-3p/SOCS3 axis may become a potential therapeutic target for diabetes.

View Figures

View References

1	Kaul K, Apostolopoulou M and Roden M: Insulin resistance in type 1 diabetes mellitus. Metabolism. 64:1629–1639. 2015. View Article : Google Scholar : PubMed/NCBI
2	Chatterjee S and Davies MJ: Current management of diabetes mellitus and future directions in care. Postgrad Med J. 91:612–621. 2015. View Article : Google Scholar : PubMed/NCBI
3	Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr and Newsholme P: Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev. 2015:1816432015. View Article : Google Scholar
4	Berge LI and Riise T: Comorbidity between type 2 diabetes and depression in the adult population: Directions of the association and its possible pathophysiological mechanisms. Int J Endocrinol. 2015:1647602015. View Article : Google Scholar : PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bhatia P, Raina S, Chugh J and Sharma S: miRNAs: early prognostic biomarkers for type 2 diabetes mellitus? Biomark Med. 2015. View Article : Google Scholar : PubMed/NCBI
7	Libânio D, Dinis-Ribeiro M and Pimentel-Nunes P: Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol. 6:111–132. 2015. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
9	Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
10	Martinez-Sanchez A, Nguyen-Tu MS and Rutter GA: DICER inactivation identifies oancreatic β-cell 'Disallowed' genes targeted by MicroRNAs. Mol Endocrinol. 29:1067–1079. 2015. View Article : Google Scholar : PubMed/NCBI
11	Latreille M, Herrmanns K, Renwick N, Tuschl T, Malecki MT, McCarthy MI, Owen KR, Rülicke T and Stoffel M: miR-375 gene dosage in pancreatic β cells: Implications for regulation of β cell mass and biomarker development. J Mol Med Berl. 93:1159–1169. 2015. View Article : Google Scholar
12	Jacovetti C, Matkovich SJ, Rodriguez-Trejo A, Guay C and Regazzi R: Postnatal β cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat Commun. 6:80842015. View Article : Google Scholar
13	Al-Kafaji G, Al-Mahroos G, Alsayed NA, Hasan ZA, Nawaz S and Bakhiet M: Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol Med Rep. 12:7485–7490. 2015.PubMed/NCBI
14	Busch S, Auth E, Scholl F, Huenecke S, Koehl U, Suess B and Steinhilber D: 5-Lipoxygenase is a direct target of miR-19a-3p and miR-125b-5p. J Immunol. 194:1646–1653. 2015. View Article : Google Scholar : PubMed/NCBI
15	Yang J, Zhang Z, Chen C, Liu Y, Si Q, Chuang TH, Li N, Gomez-Cabrero A, Reisfeld RA, Xiang R and Luo Y: MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene. Oncogene. 33:3014–3023. 2014. View Article : Google Scholar
16	Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, Zhang Y, Shi Y, Xia X, Wang S, et al: Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol. 17:383–391. 2015.
17	Ibarrola-Villava M, Llorca-Cardeñosa MJ, Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S, Navarro S, Ribas G and Cervantes A: Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer. Oncotarget. 6:26935–26945. 2015. View Article : Google Scholar : PubMed/NCBI
18	Balci S, Ayaz L, Gorur A, Yildirim Yaroglu H, Akbayir S, Dogruer Unal N, Bulut B, Tursen U and Tamer L: microRNA profiling for early detection of nonmelanoma skin cancer. Clin Exp Dermatol. 41:346–351. 2016. View Article : Google Scholar
19	Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J and Wang C: Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer. 111:1985–1992. 2014. View Article : Google Scholar : PubMed/NCBI
20	Zhu Y, Tian F, Li H, Zhou Y, Lu J and Ge Q: Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet. 130:49–53. 2015. View Article : Google Scholar : PubMed/NCBI
21	Dou L, Meng X, Sui X, Wang S, Shen T, Huang X, Guo J, Fang W, Man Y, Xi J and Li J: miR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes. Sci Rep. 5:116022015. View Article : Google Scholar : PubMed/NCBI
22	Chakraborty C, George Priya Doss C and Bandyopadhyay S: miRNAs in insulin resistance and diabetes-associated pancreatic cancer: The 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr Drug Targets. 14:1110–1117. 2013. View Article : Google Scholar : PubMed/NCBI
23	Wang X, Wang L, Mo Q, Jia A, Dong Y and Wang G: A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis. Oncol Rep. 35:518–523. 2016.
24	Tan Y, Yin H, Zhang H, Fang J, Zheng W, Li D, Li Y, Cao W, Sun C, Liang Y, et al: Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer. Oncotarget. 6:17391–17403. 2015. View Article : Google Scholar : PubMed/NCBI
25	Zheng Y, Wang Z, Tu Y, Shen H, Dai Z, Lin J and Zhou Z: miR-101a and miR-30b contribute to inflammatory cytokine- mediated β cell dysfunction. Lab Invest. 95:1387–1397. 2015. View Article : Google Scholar : PubMed/NCBI
26	Leung CM, Chen TW, Li SC, Ho MR, Hu LY, Liu WS, Wu TT, Hsu PC, Chang HT and Tsai KW: MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. Oncol Rep. 31:2147–2156. 2014.PubMed/NCBI
27	Jiang WL, Zhang YF, Xia QQ, Zhu J, Yu X, Fan T and Wang F: MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol Biol. 16:112015. View Article : Google Scholar : PubMed/NCBI
28	Kim MH, Kim MS, Kim W, Kang MA, Cacalano NA, Kang SB, Shin YJ and Jeong JH: Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells. PLoS One. 10:e01231332015. View Article : Google Scholar : PubMed/NCBI
29	Wunderlich CM, Hövelmeyer N and Wunderlich FT: Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT. 2:e238782013.PubMed/NCBI
30	Krebs DL and Hilton DJ: A new role for SOCS in insulin action. Suppressor of cytokine signaling. Sci STKE. 2003:PE62003.PubMed/NCBI
31	Yang Z, Hulver M, McMillan RP, Cai L, Kershaw EE, Yu L, Xue B and Shi H: Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One. 7:e474932012. View Article : Google Scholar : PubMed/NCBI
32	Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, Yin G, Li X and Xiang M: SOCS3 methylation in synergy with Reg3A over-expression promotes cell growth in pancreatic cancer. J Mol Med Berl. 92:1257–1269. 2014. View Article : Google Scholar